BioAffinity Technologies Inc. (BIAF)
NASDAQ · Healthcare
BioAffinity Technologies Inc. Shareholder Equity 2022–2025
BioAffinity Technologies Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BioAffinity Technologies Inc. shareholder equity for the quarter ending December 31, 2025 were 7.3M, a 179.69% increase year-over-year.
- BioAffinity Technologies Inc. shareholder equity for 2025 were 7.3M, a 179.69% increase from 2024.
- BioAffinity Technologies Inc. shareholder equity for 2024 were 2.6M, a 46.41% decrease from 2023.
- BioAffinity Technologies Inc. shareholder equity for 2023 were 4.9M, a 56.03% decrease from 2022.
- BioAffinity Technologies Inc. shareholder equity for 2022 were 11.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BioAffinity Technologies Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $3 |
| 2023 | $5 |
| 2022 | $11 |
| BioAffinity Technologies Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $7 |
| 2024-12-31 | $3 |
| 2023-12-31 | $5 |
| 2022-12-31 | $11 |
BioAffinity Technologies Inc. Shareholder Equity — FAQ
BioAffinity Technologies Inc. (BIAF) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIAF's shareholder equity history?
The chart and table above show BioAffinity Technologies Inc.'s shareholder equity by year and by quarter, including the growth rate.